| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 02/20/2003 | WO2002060874A8 Potassium channel inhibitors |
| 02/20/2003 | WO2002049993A3 High affinity small molecule c5a receptor modulators |
| 02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036667 Heating aromatic compound substituted with halogen that is exchangeable for fluorine with fluoride and compound such as Diethylaminobis(tetramethylguanidino)sulfonium bromide to produce fluorinated aromatics |
| 02/20/2003 | US20030036655 2-(substituted-phenyl)amino-imidazoline derivatives |
| 02/20/2003 | US20030036557 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 02/20/2003 | CA2457433A1 Novel alpha adrenergic agents |
| 02/20/2003 | CA2456144A1 A group of novel anti-cancer compounds with specific structure |
| 02/19/2003 | EP1284276A1 Conjugated copolymers of dithienothiophene with vinylene or acetylene |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283711A1 Peptide deformylase inhibitors |
| 02/19/2003 | EP1020179A4 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/19/2003 | EP0944603B1 Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives |
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/19/2003 | CN1101816C Substituted purine derivatives, processes for their prepn. their use, and compsns. comprising them |
| 02/18/2003 | US6521683 Antistatic agents and resin compositions incorporated therein |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
| 02/18/2003 | US6521616 Administering taurolidine, taurultam, or a biologically active derivative; induces tumor cell death by apoptosis. |
| 02/18/2003 | US6521395 Infrared couplers for incorporating and recovering metadata |
| 02/13/2003 | WO2003012900A1 Novel onium salt, electrolyte for nonaqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 02/13/2003 | WO2003011799A1 Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
| 02/13/2003 | WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 02/13/2003 | WO2002033110A3 PRODUCTION OF α-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 02/13/2003 | US20030032635 Heterocyclic esters and amides |
| 02/13/2003 | US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 02/13/2003 | US20030031704 Liposome composition for delivery of nucleic acid |
| 02/12/2003 | EP1283240A1 Imidazolidinone derivatives |
| 02/12/2003 | EP1282630A1 Hydroxylamine esters as polymerization initiators |
| 02/12/2003 | EP1282612A2 Alkynyl phenyl heteroaromatic glucokinase activators |
| 02/12/2003 | EP1282605A2 Thioimidazolidine derivatives as light stabilisers for polymers |
| 02/12/2003 | EP1282602A1 Propanoic acid derivatives as integrin receptor antagonists |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282417A1 Creatinine biosensor |
| 02/12/2003 | CN1101384C Process for preparing 1-biphenylmethylmidazole derivatives |
| 02/11/2003 | US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| 02/11/2003 | US6518295 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of troubles mediated by an excess of substance P |
| 02/11/2003 | US6518293 Anti-HIV imidazolone derivatives |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518257 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
| 02/11/2003 | US6518240 Composition and method for preparing amino acid chelates and complexes |
| 02/11/2003 | CA2222851C Keratin fibre oxidation dye composition and dye process using the composition |
| 02/11/2003 | CA2085584C Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/06/2003 | WO2002066418A3 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030027829 Potassium channel inhibitors |
| 02/06/2003 | US20030027807 Vitronectin receptor antagonists, their preparation and their use |
| 02/06/2003 | US20030027794 N-heterocyclic derivatives as NOS inhibitors |
| 02/06/2003 | US20030027239 Creatinine biosensor |
| 02/06/2003 | US20030026521 Optical interleaver |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1281709A1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280793A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 02/05/2003 | EP1280791A1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 02/05/2003 | EP1280779A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | EP1037868B1 $g(a)-HYDROXY, -AMINO, AND HALO DERIVATIVES OF $g(b)-SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASES INHIBITORS |
| 02/05/2003 | CN1395567A New imidazole derivatives |
| 02/05/2003 | CN1395558A Substituted benzoylguanidines, method for their production, their use as medicament or diagnostic agent and mediciment containing same |
| 02/05/2003 | CN1100777C N-heterocyclic derivatives as NOS inhibitor |
| 02/05/2003 | CN1100763C Process for producing imidazole derivatives |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/05/2003 | CN1100534C 2-(1H-4(5)-imidazoyl cyclopropyl derivatives and drug coposition containig the same, and preparing method thereof |
| 02/04/2003 | US6515138 Transesterification process |
| 02/04/2003 | US6515137 Enantioselectivity of alpha,beta-unsaturated aldehydes |
| 02/04/2003 | US6515133 Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. |
| 02/04/2003 | US6515124 Dehydroamino acids |
| 02/04/2003 | US6515023 Thrombin receptor antagonists |
| 02/04/2003 | US6515003 Useful in the treatment of diseases related to lipid and carbohydrate metabolism |
| 02/04/2003 | US6514993 Serotonin 5-HT1A and dopamin D2 receptor ligands |
| 02/04/2003 | US6514985 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/04/2003 | US6514966 Compounds for the treatment of obesity |
| 02/04/2003 | US6514952 For the treatment and prophylaxis of diseases which are caused by an undesired extent of leucocyte adhesion and/or leucocyte migration such as rheumatoid arthritis or allergic disorders |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 02/04/2003 | US6514664 Radiation sensitive compositions containing image quality and profile enhancement additives |
| 01/31/2003 | CA2396020A1 Imidazolidinone derivatives |
| 01/30/2003 | WO2003008386A2 Process for the preparation of the enantiomeric forms of 2-substituted 2-(2,5-dioxoimidazolidin-1-yl)-acetic acid derivatives |
| 01/30/2003 | WO2003007887A2 Substituted imidazoles as cannabinoid receptor modulators |
| 01/30/2003 | US20030023098 Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
| 01/30/2003 | US20030022891 Melanin-concentrating hormone (MCH); treating metabolic and eating disorders, such as hyperphagia, and diabetes; urea, thiourea and cyano-guanidine compounds of given formula |
| 01/30/2003 | US20030022865 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 01/30/2003 | CA2453753A1 Process for the preparation of the enantiomeric forms of 2-substituted 2-(2,5-dioxoimidazolidin-1-yl)-acetic acid derivatives |
| 01/29/2003 | EP1279667A1 Process for producing 1,3-dialkyl-2-imidazolidinone compound |
| 01/29/2003 | EP1278719A1 Naphthamide neurokinin antagonists for use as medicaments |
| 01/29/2003 | EP1192145A4 Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines |
| 01/29/2003 | EP1030836B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 01/29/2003 | EP1028948B1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 01/29/2003 | CN1394203A Piperidine and piperazine derivatives which function as 5-HT2A receptor antagonists |
| 01/28/2003 | WO2002010155A1 Substituted aryl ketones and their use as herbicides |
| 01/28/2003 | US6511991 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |